Structure |
Chemical Name |
CAS |
MF |
![Umeclidinium Bromide Impurity 4](/CAS/20210111/GIF/869112-31-2.gif) |
Umeclidinium Bromide Impurity 4 |
869112-31-2 |
C22H28BrNO2 |
![Deschloro Etoricoxib](/) |
Deschloro Etoricoxib |
|
|
![Cefazolin impurity B](/CAS/20211123/GIF/1798004-55-3.gif) |
Cefazolin impurity B |
1798004-55-3 |
C16H20N4O4S3.Na |
![5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide](/CAS/20200611/GIF/1632463-24-1.gif) |
5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide |
1632463-24-1 |
C38H36Cl2N6O10S2 |
![Rivaroxaban Impurity 16](/) |
Rivaroxaban Impurity 16 |
|
|
![Topiroxostat Impurity 3](/) |
Topiroxostat Impurity 3 |
|
|
![Diroxide Impurity 4](/) |
Diroxide Impurity 4 |
|
|
![(R,E)-4-((3-(3-(diisopropylamino)-1-phenylpropyl)-4-hydroxybenzyl)oxy)-4-oxobut-2-enoic acid](/CAS/20200331/GIF/CB23129542.gif) |
(R,E)-4-((3-(3-(diisopropylamino)-1-phenylpropyl)-4-hydroxybenzyl)oxy)-4-oxobut-2-enoic acid |
|
C26H33NO5 |
![Flomoxef Impurity 2](/CAS/20200515/GIF/1208982-59-5.gif) |
Flomoxef Impurity 2 |
1208982-59-5 |
C32H30N6O7S |
![Lincomycin impurity B](/) |
Lincomycin impurity B |
|
|
![Valsartan Impurity 1](/CAS/20180629/GIF/914465-68-2.gif) |
Valsartan Impurity 1 |
914465-68-2 |
C19H21N5O |
![Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, sulfate (1:1)](/CAS/20211123/GIF/52144-93-1.gif) |
Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, sulfate (1:1) |
52144-93-1 |
C33H37NO7S |
![2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol](/CAS/20180702/GIF/CB23143889.gif) |
2-(((3aS,4R,6S,6aR)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol |
|
C17H27ClN4O4S |
![Clindamycin impurity](/CAS/20211123/GIF/198080-64-7.gif) |
Clindamycin impurity |
198080-64-7 |
C18H32N2O5S |
![Digoxin impurity](/) |
Digoxin impurity |
|
|
![Lamivudine impurity](/) |
Lamivudine impurity |
|
|
![Levothyroxine Sodium impurity](/CAS/20210111/GIF/27566-09-2.gif) |
Levothyroxine Sodium impurity |
27566-09-2 |
C14H21NO4 |
![Dexchlorpheniramine impurity](/CAS/20210305/GIF/73775-50-5.gif) |
Dexchlorpheniramine impurity |
73775-50-5 |
C12H15ClN2 |
![6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one](/CAS/20180702/GIF/869478-11-5.gif) |
6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one |
869478-11-5 |
C17H16ClNO4 |
![ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/77549-94-1.gif) |
ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
77549-94-1 |
C22H26N2O2 |
![Dolutegravir Impurity 2](/) |
Dolutegravir Impurity 2 |
|
|
![Lesinurad Impurity J](/CAS/20180808/GIF/1210330-64-5.gif) |
Lesinurad Impurity J |
1210330-64-5 |
C14H10BrN3O2S |
![Neratinib Impurity 4](/CAS/20211123/GIF/1144516-18-6.gif) |
Neratinib Impurity 4 |
1144516-18-6 |
C31H32ClN6O3+ |
![Linagliptin Impurity C](/CAS/20210111/GIF/1791405-13-4.gif) |
Linagliptin Impurity C |
1791405-13-4 |
C15H20N6O2 |
![1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-](/CAS/20180808/GIF/849221-94-9.gif) |
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl- |
849221-94-9 |
C28H25N3O5 |
![methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/57430-34-9.gif) |
methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
57430-34-9 |
C22H28N2O4 |
![(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone](/CAS/20180527/GIF/1288338-95-3.gif) |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]ethanone |
1288338-95-3 |
C24H24N6O2 |
![Amlodipine Impurity 17](/CAS/20180702/GIF/CB23159167.gif) |
Amlodipine Impurity 17 |
|
C26H31ClN2O8S |
![Edoxaban Impurity 12 (1R,2R,4S)](/) |
Edoxaban Impurity 12 (1R,2R,4S) |
|
|
![Rivaroxaban Impurity 26](/CAS/20210111/GIF/1838133-00-8.gif) |
Rivaroxaban Impurity 26 |
1838133-00-8 |
C23H21Cl2N3O5S2 |
![Erlotinib](/CAS/20200611/GIF/938185-06-9.gif) |
Erlotinib |
938185-06-9 |
C16H11N3O2 |
![methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20180808/GIF/18374-18-0.gif) |
methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
18374-18-0 |
C21H26N2O3 |
![Brexpiprazole sulfoxide impurity](/CAS/20200611/GIF/1191900-51-2.gif) |
Brexpiprazole sulfoxide impurity |
1191900-51-2 |
C25H27N3O3S |
![Cabozantinib Impurity H](/) |
Cabozantinib Impurity H |
|
|
![Clopidogrel Impurity 11](/CAS/20180629/GIF/CB23166437.gif) |
Clopidogrel Impurity 11 |
|
C15H14ClNO2S |
![Medetomidine Impurity 3](/CAS/20180808/GIF/104245-83-2.gif) |
Medetomidine Impurity 3 |
104245-83-2 |
C10H13Cl |
![Tofacitinib Impurity 35](/) |
Tofacitinib Impurity 35 |
|
|
![ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate](/CAS/20200331/GIF/1884279-18-8.gif) |
ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate |
1884279-18-8 |
C18H17NO4S |
![N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate](/CAS/20180527/GIF/928325-82-0.gif) |
N-methyl-1-(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate |
928325-82-0 |
C21H21N3O6S |
![Phenol, 2,4-dibromo-3-methyl-](/CAS/20180528/GIF/13321-75-0.gif) |
Phenol, 2,4-dibromo-3-methyl- |
13321-75-0 |
C7H6Br2O |
![N-((4-FLUOROPHENYL)METHYL)ETHANAMIDE](/CAS/GIF/86010-68-6.gif) |
N-((4-FLUOROPHENYL)METHYL)ETHANAMIDE |
86010-68-6 |
C9H10FNO |
![Benzenediazonium, 4-(ethoxycarbonyl)-, chloride](/CAS/20200331/GIF/2028-79-7.gif) |
Benzenediazonium, 4-(ethoxycarbonyl)-, chloride |
2028-79-7 |
C9H9ClN2O2 |
![2,4-Pteridinediamine,6-(methoxymethyl)-](/CAS/20180529/GIF/40110-13-2.gif) |
2,4-Pteridinediamine,6-(methoxymethyl)- |
40110-13-2 |
C8H10N6O |
![Fingolimod EP Impurity D](/CAS/20180528/GIF/780729-32-0.gif) |
Fingolimod EP Impurity D |
780729-32-0 |
C21H37NO2 |
![Pentanedioic acid, 2,4-diacetyl-3-(3-nitrophenyl)-, dimethyl ester](/CAS/20180529/GIF/89080-61-5.gif) |
Pentanedioic acid, 2,4-diacetyl-3-(3-nitrophenyl)-, dimethyl ester |
89080-61-5 |
C17H19NO8 |
![2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI)](/CAS/20180808/GIF/130609-10-8.gif) |
2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI) |
130609-10-8 |
C12H18NNaO6S |
![4,4'-Iminodiphenol hydrochloride](/CAS/20180601/GIF/1965310-24-0.gif) |
4,4'-Iminodiphenol hydrochloride |
1965310-24-0 |
C12H12ClNO2 |
![Cefradine Impurity D](/) |
Cefradine Impurity D |
|
|
![Donepezil Impurity](/CAS/20180527/GIF/896134-06-8.gif) |
Donepezil Impurity |
896134-06-8 |
C17H15NO4 |
![1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine](/CAS/20180527/GIF/928325-68-2.gif) |
1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
928325-68-2 |
C17H15ClFN3O2S |
![N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide](/CAS/20180527/GIF/2037385-84-3.gif) |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
2037385-84-3 |
C13H19ClN4O3 |
![N-(3,5-dimethylphenyl)picolinamide](/CAS/20200331/GIF/439591-67-0.gif) |
N-(3,5-dimethylphenyl)picolinamide |
439591-67-0 |
C14H14N2O |
![Neratinib Impurity 6](/CAS/20200611/GIF/1144516-14-2.gif) |
Neratinib Impurity 6 |
1144516-14-2 |
C26H21ClN6O4 |
![Bupivacaine Impurity](/CAS/20210111/GIF/852804-30-9.gif) |
Bupivacaine Impurity |
852804-30-9 |
C22H37N2O |
![Pseudomonic Acid D](/CAS/20211123/GIF/85248-93-7.gif) |
Pseudomonic Acid D |
85248-93-7 |
C26H42O9 |
![Terazosin Impurity](/CAS/20180527/GIF/60548-08-5.gif) |
Terazosin Impurity |
60548-08-5 |
C19H25N5O4 |
![1204612-29-2](/CAS/20211123/GIF/1204612-29-2.gif) |
1204612-29-2 |
1204612-29-2 |
C12H18ClNO2 |
![(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol](/CAS/20180527/GIF/1384080-56-1.gif) |
(S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol |
1384080-56-1 |
C9H15NOS |
![BDJS-SH 4](/CAS/20210111/GIF/36588-46-2.gif) |
BDJS-SH 4 |
36588-46-2 |
C12H18N2O2 |
![3-Chloro TirofiBan](/CAS/20181212/GIF/CB23358885.gif) |
3-Chloro TirofiBan |
2713130-63-1 |
C22H35ClN2O5S |
![Azelastine EP Impurity E](/CAS/20180808/GIF/105279-16-1.gif) |
Azelastine EP Impurity E |
105279-16-1 |
C15H9ClO2 |
![Blonanserin impurity F](/) |
Blonanserin impurity F |
|
|
![Capecitabine Impurity 9](/) |
Capecitabine Impurity 9 |
|
|
![Carfilzomib Impurity E](/) |
Carfilzomib Impurity E |
|
|
![Cefoxitin EP Impurity B](/) |
Cefoxitin EP Impurity B |
|
|
![Dabigatran Impurity 3](/) |
Dabigatran Impurity 3 |
|
|
![Dexamethasone EP Impurity K](/CAS/20210305/GIF/1809224-82-5.gif) |
Dexamethasone EP Impurity K |
1809224-82-5 |
C22H26O4 |
![FeBuxostat Impurity 41](/CAS/20210111/GIF/2428631-67-6.gif) |
FeBuxostat Impurity 41 |
2428631-67-6 |
C19H19N3O3S |
![Formoterol Impurity 16](/) |
Formoterol Impurity 16 |
|
|
![Indacaterol Impurity 11](/) |
Indacaterol Impurity 11 |
|
|
![Isavuconazole Impurity 14](/) |
Isavuconazole Impurity 14 |
|
|
![Isavuconazole Impurity 19](/) |
Isavuconazole Impurity 19 |
|
|
![Isavuconazole Impurity 24](/CAS/20210111/GIF/1176988-44-5.gif) |
Isavuconazole Impurity 24 |
1176988-44-5 |
C22H17F2N5OS |
![Letrozole Impurity 10](/) |
Letrozole Impurity 10 |
|
|
![Levofloxacin Impurity 9](/CAS/20180527/GIF/1797099-76-3.gif) |
Levofloxacin Impurity 9 |
1797099-76-3 |
C18H20FN3O4 |
![N-(5-Formyl-2-hydroxyphenyl)formamide](/CAS/20180527/GIF/903563-43-9.gif) |
N-(5-Formyl-2-hydroxyphenyl)formamide |
903563-43-9 |
C8H7NO3 |
![Nitrendipine Impurity 5](/) |
Nitrendipine Impurity 5 |
|
|
![Posaconazole Impurity 32](/) |
Posaconazole Impurity 32 |
|
|
![Posaconazole Impurity 61](/) |
Posaconazole Impurity 61 |
|
|
![Procaterol Impurity 4](/CAS/20200611/GIF/63235-39-2.gif) |
Procaterol Impurity 4 |
63235-39-2 |
C16H20N2O3 |
![Sitagliptin Impurity 14](/CAS/20211123/GIF/2072867-07-1.gif) |
Sitagliptin Impurity 14 |
2072867-07-1 |
C26H23F9N6O2 |
![SofosBuvir Impurity 31](/) |
SofosBuvir Impurity 31 |
|
|
![sofosBuvir Impurity 37](/) |
sofosBuvir Impurity 37 |
|
|
![SofosBuvir Impurity 53](/CAS/20210111/GIF/1015255-46-5.gif) |
SofosBuvir Impurity 53 |
1015255-46-5 |
C20H25FN3O9P |
![Sofosbuvir Impurity 60](/) |
Sofosbuvir Impurity 60 |
|
|
![Tenofovir impurity G](/) |
Tenofovir impurity G |
|
|
![Ticagrelor Impurity 26](/CAS/20200611/GIF/2245167-79-5.gif) |
Ticagrelor Impurity 26 |
2245167-79-5 |
C21H24F2N6O3S |
![Vildagliptin Impurity 19](/CAS/20180808/GIF/243145-00-8.gif) |
Vildagliptin Impurity 19 |
243145-00-8 |
C10H16N2O2 |
![Olopatadine Isopropyl ester Hydrochloride](/CAS/20180808/GIF/1206456-44-1.gif) |
Olopatadine Isopropyl ester Hydrochloride |
1206456-44-1 |
C24H29NO3 |
![GLATIRAMER impurity](/) |
GLATIRAMER impurity |
|
|
![Oxacillin Sodium Impurity I(EP)](/) |
Oxacillin Sodium Impurity I(EP) |
|
|
![Spectinomycin Impurity E](/) |
Spectinomycin Impurity E |
|
|
![3-butyl-3-hydroxy-2-benzofuran-1-one](/CAS/20180527/GIF/162050-42-2.gif) |
3-butyl-3-hydroxy-2-benzofuran-1-one |
162050-42-2 |
C12H14O3 |
![(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline)](/) |
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (minocycline) |
|
|
![(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione](/CAS/20180527/GIF/2088771-61-1.gif) |
(R)-10-(2,4,5-trifluorobenzyl)-3-(trifluoromethyl)-6,7,10,11-tetrahydro-[1,2,4]triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione |
2088771-61-1 |
C16H13F6N5O2 |
![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180629/GIF/1092578-45-4.gif) |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
1092578-45-4 |
C20H25N5 |
![846023-56-1](/CAS/20200515/GIF/846023-56-1.gif) |
846023-56-1 |
846023-56-1 |
C26H31Cl2N5O4 |
![Prednisone impurity D (EP)](/CAS/20180527/GIF/10184-69-7.gif) |
Prednisone impurity D (EP) |
10184-69-7 |
C21H26O4 |
![Lisinopril EP Impurity G](/CAS/20180527/GIF/1356839-89-8.gif) |
Lisinopril EP Impurity G |
1356839-89-8 |
C42H60N6O9 |
![2-hexanoylbenzoic acid](/CAS/20180527/GIF/857538-11-5.gif) |
2-hexanoylbenzoic acid |
857538-11-5 |
C13H16O3 |